Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders

US Patent 12059454 · Granted Aug 13, 2024

Assignee

Inventors

View full patent text on Google Patents →